Search

You searched for "interview"

1625 results found

In conversation with John Forrester

2 December 2019 | | EYE - General
What made you choose ophthalmology as a career and how did your interest in academia develop? During Medical School at Glasgow University, I was getting progressively disillusioned with the career options while my colleagues and friends all seemed to quickly...

Harry Moss Traquair: Edinburgh Ophthalmologist and Father Figure of Perimetry

3 February 2023 | | EYE - General
It is a unique honour bestowed upon only a few clinicians, that their name becomes for evermore associated with the subject of their particular expertise and knowledge. Such an individual is undoubtedly Harry Moss Traquair, an Edinburgh-based ophthalmologist, who in...

Sustainability in ophthalmology and healthcare: An overview

2 April 2025 | | EYE - General
Finally, even staunch sceptics are coming around to recognising that climate change is real and that we should do something about it. But how proximal the threat is and at what pace change has to happen is not universally agreed...

Strengthening the signal: Advancing oculomics research for systemic health insights

4 December 2024 | | EYE - Imaging
Oculomics, the study of how ocular structure reflects systemic health, is poised to become an integral tool for predicting, triaging, and diagnosing a wide range of diseases. By analysing data from the eye, particularly the retina, healthcare providers can gain...

SOS (Simplified Ophthalmic Statistics) Part 3: Which statistical test should I use (if any)?

4 December 2018 | | EYE - General
P<0.05 is a statement that brings joy to many researchers. Arguably this is because inclusion of such a statement may increase the chance of acceptance for publication. Whilst statisticians and non-statisticians are united in trying to change this culture, cultural...

Optegra celebrates 15th anniversary and announces expansion plans

18 September 2023 | Optegra, MP, Angela Richardson, Eye Hospital, Anniversary, 15th
Specialist eye hospital Optegra marks its 15th anniversary this month, having opened its first UK hospital in Guildford in 2008.

My Top Five: Tips for organising and delivering a national ophthalmology educational series

2 October 2025 | | EYE - General
Organising a national teaching series is both deeply rewarding and surprisingly complex. It requires more than just good content – it demands a well-thought-out purpose, seamless logistics, strong communication and meaningful evaluation. Over the past year, I had the opportunity...

Moorfields Eye Charity’s six-year growth and impact

12 July 2024 | industry, infrastructure, Moorfields, eyecare, eclo, report
Moorfields Eye Charity launches its impact report showing that it has grown to become the leading charity in the UK funding research into eye health and innovation and improvement in patient care.

“We’ve done it!”  Blind London lawyer and boss climb 24 peaks in 24 hours for charity, SeeAbility

11 September 2024 | charity, community, Leber's optic neuropathy, optic nerve, patient stories, fundraising
“We’ve done it!” Blind London lawyer and his sighted boss succeed in climbing 24 peaks in 24 hours raising tens of thousands of pounds for 225-year-old disability charity SeeAbility.

Glasgow-based eye surgeon, Dr Tim Lavy, speaks into new vision and new life for Mamadou

12 November 2024 | paediatric, patient stories, international, charity, cataract, surgery, Africa
The moment a seven-year-old boy sees clearly for the first time has been captured in a video by the charity that gave him free surgery. Surgeons from international charity Mercy Ships believe Mamadou, who lives in Sierra Leone, would have...

Treatment for cause of sudden sight loss now available through the NHS in England

24 September 2025 | LHON, NICE, vision Loss, mitochondrial disease, NHS England
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...

NICE approves treatment for cause of sudden sight loss

15 October 2025 | genetics, neuro-ophthalmology, drugs, new treatments, mitochondrial
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...